DashboardAll companies
Run this on your own research
Healthcare · Diagnostics & Research

IQVIA Holdings Inc.

IQVNYSE$279.36+$1.04 (+0.37%)Market closed

Price Chart

Daily

Key facts

Market Cap
$46.40B
P/E
35.3x
P/B
7.38x
ROE
21.6%

IQVIA Holdings Inc.

Healthcare · Diagnostics & Research · FY 2025

IQVIA Holdings Inc. is a leading global provider of technology solutions, advanced analytics, and clinical research services, primarily serving the life sciences and healthcare industries. The company plays a critical role in supporting pharmaceutical, biotechnology, and medical device organizations across the continuum of drug development, from early-stage clinical trials (Phase I–IV) to post-market analysis. IQVIA’s operations are organized into three main segments: Technology & Analytics Solutions, which delivers cloud-based applications, healthcare data management, and consulting; Research & Development Solutions, which offers comprehensive contract research services for clinical trials; and Contract Sales & Medical Solutions, focused on commercial outsourcing and patient engagement. Its vast database covers anonymized health records from over one billion individuals globally, empowering clients to generate real-world evidence and make informed decisions that drive innovation and improve patient outcomes. With a workforce of nearly 90,000 employees in over 100 countries, IQVIA is recognized for its domain expertise, global reach, and role in accelerating healthcare transformation through connected intelligence and next-generation technology.

CEO
Mr. Ari Bousbib
Employees
90,000
Website
iqvia.com

Company Statistics

Valuation

P/E
35.3x
P/B
7.38x
P/S
2.94x
EV/EBITDA
17.4x
P/FCF
23.4x

Margins

Gross
33.3%
EBITDA
21.9%
Operating
14.0%
Pre-Tax
9.8%
Net
8.3%

Returns

ROA
4.8%
ROE
21.6%
ROIC
8.2%

Growth (CAGR)

Rev 3Yr
4.2%
Rev 5Yr
7.5%
Op Inc 3Yr
7.8%
Net Inc 3Yr
7.6%

Financial Health

Cash & Cash Equivalents
$1.98B
Net Debt
$21.33B
Debt/Equity
351.6%
Interest Cov
—

Profile

Revenue
$16.31B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
IQVIA Holdings Inc. (IQV) Stock Forecast 2026 $279.36 — Price, Financials & Analyst Targets | AlphaLenz